Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392,193,323
-
Total 13F shares
-
362,126,628
-
Share change
-
-2,842,279
-
Total reported value
-
$24,355,702,385
-
Put/Call ratio
-
110%
-
Price per share
-
$67.29
-
Number of holders
-
891
-
Value change
-
-$451,161,102
-
Number of buys
-
432
-
Number of sells
-
471
Institutional Holders of DEXCOM INC - Common Stock (DXCM) as of Q3 2025
As of 30 Sep 2025,
DEXCOM INC - Common Stock (DXCM) was held by
891 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
362,126,628 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, BAILLIE GIFFORD & CO, GEODE CAPITAL MANAGEMENT, LLC, JENNISON ASSOCIATES LLC, UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC, CITADEL ADVISORS LLC, Nuveen, LLC, and JPMORGAN CHASE & CO.
This page lists
891
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.